EI
CLVS

EAM Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

EAM Investors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,073
Closed -$2.48M – 369
2017
Q3 		$2.48M Sell
30,073
-12,221
-29% -$969K 0.33% 118
2017
Q2 		$3.96M Sell
42,294
-15,588
-27% -$954K 0.65% 25
2017
Q1 		$3.69M Buy
+57,882
New +$3.52M 0.58% 40
2015
Q4 		– Sell
-31,678
Closed -$2.91M – 368
2015
Q3 		$2.91M Sell
31,678
-16,418
-34% -$1.42M 0.46% 67
2015
Q2 		$4.23M Buy
+48,096
New +$4.12M 0.49% 57
2013
Q3 		– Sell
-14,584
Closed -$977K – 378
2013
Q2 		$977K Buy
+14,584
New +$656K 0.21% 249

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EAM Investors's CLVS Position: Q4 2017 in Review

EAM Investors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 30,073 shares — an estimated $2.48M sold.

EAM Investors first reported a position in CLVS in Q2 2013 and held it in 6 quarters. The position peaked at $4.23M in Q2 2015. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • EAM Investors reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • EAM Investors sold 30,073 Clovis Oncology, Inc. shares in Q4 2017, an estimated $2.48M.
  • EAM Investors first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 6 quarters.
  • EAM Investors's Clovis Oncology, Inc. position peaked at $4.23M in Q2 2015.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on EAM Investors's 13F filing for Q4 2017, filed 12 Feb 2018.